![]() Insights, analysis and must reads from CNN's Fareed Zakaria and the Global Public Square team, compiled by Global Briefing editor Chris Good
Seeing this newsletter as a forward? Subscribe here.
September 15, 2021 Will Biden's Mandates Work? When President Biden announced sweeping workplace vaccine mandates last week, the US entered a new, more-mandatory phase of pandemic precaution since the lifting of restrictions and the arrival of vaccines. Afghan Women Fight for Their Rights Since the Taliban's takeover, Afghan women have protested for rights under the new regime, as Ezzatullah Mehrdad writes for Newlines Magazine—and the Taliban have "responded with beatings and abuse, leaving the women no choice but to look outside for help." Quoting one female activist who calls on the international community to deny the Taliban diplomatic recognition unless women's rights are ensured, Mehrdad writes also of discontent with Western aid efforts that sought to develop rights for women in Afghanistan but, in the eyes of some, failed to embed them durably. 'Al Qaeda Versus ISIS' As international observers wonder if Afghanistan will again become a terrorist sanctuary, Cole Bunzel reminds us in a Foreign Affairs essay that jihadism is anything but monolithic. Al Qaeda has seen its star fall in recent years, but it has maintained ties with the Taliban and has praised the latter's takeover of Afghanistan, Bunzel writes. Meanwhile, "[f]or ISIS," the Taliban's seizure of power "is not a triumph at all but rather further evidence of the Taliban's willingness to collaborate with the Americans" as US and NATO troops withdrew. About Those Abraham Accords Have the Abraham Accords succeeded, or have they failed miserably? Would China Move to mRNA? Having produced and exported its own vaccines, would China pivot to deploying mRNA-based shots like those developed by Pfizer/BioNTech and Moderna? At SupChina, Lucas Niewenhuis asks that question, citing recent Covid-19 outbreaks in China; unease with the efficacy rates of China's vaccines; reports that other countries are declining them; and the testing of mRNA shots for potential use in China—including Chinese-made mRNA vaccines and a BioNTech shot using the same platform as in its partnership with Pfizer but co-produced with a Chinese firm. FAREED'S GLOBAL BRIEFING You are receiving this newsletter because you're subscribed to Fareed's Global Briefing.
What did you like about today's Global Briefing? What did we miss? Let us know what you think: GlobalBriefing@cnn.com
No longer want to receive this newsletter? Unsubscribe. Interested in more? See all of our newsletters.
Create CNN Account | Listen to CNN Audio | Download the CNN App
® © 2021 Cable News Network, Inc. A WarnerMedia Company. All Rights Reserved. One CNN Center Atlanta, GA 30303
|